Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | BAFNAPH Bafna Pharmaceuticals Limited Pharma · Small | HALEOSLABS HALEOS LABS LIMITED Pharma · Small | ALBERTDAVD Albert David Limited Pharma · Small | ANUHPHR Anuh Pharma Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 24 | 29 | 23 | 50 |
| Verdict | OVERVALUED | OVERVALUED | OVERVALUED | FAIR VALUE |
| Style | OVERVALUED | OVERVALUED | OVERVALUED | FAIR_VALUE |
| Piotroski | 2/9 | 8/9 | 3/9 | 6/9 |
| Valuation | 5/30 | 7/30 | 5/30 | 16/30 |
| Growth | 9/25 | 8/25 | 7/25 | 12/25 |
| Quality | 0/20 | 0/20 | 0/20 | 2/20 |
| Balance Sheet | 11/15 | 9/15 | 10/15 | 12/15 |
| Cash Flow | 3/10 | 3/10 | 3/10 | 4/10 |
| Price | ₹174.58 | ₹1,407.9 | ₹710 | ₹77.55 |
| P/E | — | 23.70 | — | 18.50 |
| P/B | 0.90 | 1.92 | 1.01 | 2.16 |
| ROE | -6.18% | 8.44% | -0.38% | 12.10% |
| ROCE | -3.00% | 9.91% | 0.77% | 15.90% |
| Debt / Equity | 0.06 | 0.52 | 0.08 | 0.00 |
| FCF Yield | — | — | — | 1.98% |
| Dividend Y | — | 0.11% | 0.72% | 1.98% |
| Altman Z | 7.86 | 2.91 | 3.86 | 4.96 |
| Promoter % | 75.00% | 72.10% | 62.23% | 71.79% |
| Mkt Cap (₹Cr) | 459.00 | 410.00 | 396.00 | 759.00 |
| Graham # | — | ₹953.72 | — | ₹56.9 |
| Fair PE | 42.0 | 13.8 | 23.5 | 42.0 |
| MoS % | — | -77.9% | — | +55.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startBAFNAPH212
HALEOSLABS101
ALBERTDAVD50
ANUHPHR35